等待开盘 06-26 09:30:00 美东时间
-0.065
-3.12%
Receipt of award notice for second $1.0 million tranche of NIAID funding brings total NIH funding award for DARE-HPV to $2.0 millionFunding award milestone follows Daré's announcement last week of the initiation of its
05-26 20:15
The Phase 2 study is a randomized, placebo-controlled, double-blind trial designed to evaluate the safety and antiviral activity of a lower and higher DARE-HPV dose compared with placebo in approximately 100 women with
05-18 20:02
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonal topical cream shown in clinical studies to increase genital blood flow in
2025-12-10 21:08
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that all rights to
2025-12-01 21:10
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that it has received
2025-11-24 21:04
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
(来源:上观新闻) 近日,兴业太古汇开启“DARE FOR MORE DARE TO ART爱混敢嗲 无尽花火”艺术季,与上海当代艺...
2025-10-20 13:12
(来源:上观新闻) 金秋十月,上海消费市场迎来多重精彩。从兴业太古汇的公共艺术盛宴,到安福路的意式咖啡时尚快闪,多样化活动不仅丰富了...
2025-10-17 16:06